Mesothelin and MUC16 (CA125) are antigen-targets for CAR T-cell therapy in primary and metastatic lung adenocarcinoma Meeting Abstract

  

Authors:	Eguchi, T.; Ujiie, H.; Morello, A.; Kadota, K.; Buitrago, D. H.; Woo, K.; Jones, D. R.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
Abstract Title:	Mesothelin and MUC16 (CA125) are antigen-targets for CAR T-cell therapy in primary and metastatic lung adenocarcinoma
Meeting Title:	16th World Conference on Lung Cancer (WCLC)
Keywords:	immunotherapy; mesothelin; muc16
Journal Title:	Journal of Thoracic Oncology
Volume:	10
Issue:	9 Suppl. 2
Meeting Dates:	2015 Sep 6-9
Meeting Location:	Denver, CO
ISSN:	1556-0864
Publisher:	Elsevier Inc.
Date Published:	2015-09-01
Start Page:	S229
Language:	English
ACCESSION:	WOS:000370365100373
PROVIDER:	wos
PUBMED:	26710300
DOI:	10.1016/S1556-0864(16)30010-7
Notes:	Meeting Abstract: ORAL28.05 -- Source: Wos